These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

430 related items for PubMed ID: 22552273

  • 1. Dysplasia and colorectal cancer in a patient with ulcerative colitis and primary sclerosing cholangitis: a case report and a short review of the literature.
    Chaparro M, Trapero-Marugán M, Guijarro M, López C, Moreno-Otero R, Gisbert JP.
    J Crohns Colitis; 2013 Mar; 7(2):e61-5. PubMed ID: 22552273
    [Abstract] [Full Text] [Related]

  • 2. Proximal colorectal dysplasia or cancer in ulcerative colitis. The impact of primary sclerosing cholangitis and sulfasalazine: results from a 20-year surveillance study.
    Lindberg BU, Broomé U, Persson B.
    Dis Colon Rectum; 2001 Jan; 44(1):77-85. PubMed ID: 11805567
    [Abstract] [Full Text] [Related]

  • 3. [Chronic inflammatory bowel diseases. Recurrence prevention = carcinoma prevention?].
    Vetter C.
    MMW Fortschr Med; 2005 Mar 31; 147(13):10. PubMed ID: 15832752
    [No Abstract] [Full Text] [Related]

  • 4. The impact of ursodeoxycholic acid on cancer, dysplasia and mortality in ulcerative colitis patients with primary sclerosing cholangitis.
    Wolf JM, Rybicki LA, Lashner BA.
    Aliment Pharmacol Ther; 2005 Nov 01; 22(9):783-8. PubMed ID: 16225486
    [Abstract] [Full Text] [Related]

  • 5. Natural history of low grade dysplasia in patients with primary sclerosing cholangitis and ulcerative colitis.
    Venkatesh PG, Jegadeesan R, Gutierrez NG, Sanaka MR, Navaneethan U.
    J Crohns Colitis; 2013 Dec 01; 7(12):968-73. PubMed ID: 23433613
    [Abstract] [Full Text] [Related]

  • 6. Ursodiol use is associated with lower prevalence of colonic neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis.
    Tung BY, Emond MJ, Haggitt RC, Bronner MP, Kimmey MB, Kowdley KV, Brentnall TA.
    Ann Intern Med; 2001 Jan 16; 134(2):89-95. PubMed ID: 11177311
    [Abstract] [Full Text] [Related]

  • 7. Steroid-refractory ulcerative colitis and associated primary sclerosing cholangitis treated with infliximab.
    Duca I, Ramírez de la Piscina P, Estrada S, Calderón R, Spicakova K, Urtasun L, Marra-López C, Zabaleta S, Bengoa R, Marcaide MA, García-Campos F.
    World J Gastroenterol; 2013 Jan 28; 19(4):590-3. PubMed ID: 23382642
    [Abstract] [Full Text] [Related]

  • 8. [Colorectal cancer in ulcerative colitis].
    Laugesen KB, Tøttrup A.
    Ugeskr Laeger; 2014 Jan 20; 176(4A):V07130441. PubMed ID: 25347248
    [Abstract] [Full Text] [Related]

  • 9. Colorectal neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis.
    Gurbuz AK, Giardiello FM, Bayless TM.
    Dis Colon Rectum; 1995 Jan 20; 38(1):37-41. PubMed ID: 7813342
    [Abstract] [Full Text] [Related]

  • 10. [Cancer Surveillance in Inflammatory Bowel Diseases].
    Lissner D, Siegmund B.
    Dtsch Med Wochenschr; 2019 Jun 20; 144(11):753-756. PubMed ID: 31163475
    [Abstract] [Full Text] [Related]

  • 11. Surgical management of ulcerative colitis in the presence of primary sclerosing cholangitis.
    Poritz LS, Koltun WA.
    Dis Colon Rectum; 2003 Feb 20; 46(2):173-8. PubMed ID: 12576890
    [Abstract] [Full Text] [Related]

  • 12. Rectal non-Hodgkin's lymphoma in an infliximab treated patient with ulcerative colitis and primary sclerosing cholangitis.
    Van Hauwaert V, Meers S, Verhoef G, Tousseyn T, Sagaert X, Vermeire S, Rutgeerts P, Van Assche G.
    J Crohns Colitis; 2010 Dec 20; 4(6):683-6. PubMed ID: 21122582
    [Abstract] [Full Text] [Related]

  • 13. Risk for colorectal neoplasia in patients with colonic Crohn's disease and concomitant primary sclerosing cholangitis.
    Braden B, Halliday J, Aryasingha S, Sharifi Y, Checchin D, Warren BF, Kitiyakara T, Travis SP, Chapman RW.
    Clin Gastroenterol Hepatol; 2012 Mar 20; 10(3):303-8. PubMed ID: 22037429
    [Abstract] [Full Text] [Related]

  • 14. [Ulcerative colitis. Cancer prevention].
    Schmiegel W, Pox C, Kroesen A.
    Z Gastroenterol; 2004 Sep 20; 42(9):1014-8. PubMed ID: 15455276
    [No Abstract] [Full Text] [Related]

  • 15. Characteristics and outcome of primary sclerosing cholangitis associated with inflammatory bowel disease in Asian children.
    Lee WS, Karthik SV, Ng RT, Ong SY, Ong C, Chiou FK, Wong SY, Quak SH, Aw MM.
    Pediatr Neonatol; 2019 Aug 20; 60(4):396-404. PubMed ID: 31409456
    [Abstract] [Full Text] [Related]

  • 16. Increased risk of colorectal cancer and dysplasia in patients with Crohn's colitis and primary sclerosing cholangitis.
    Lindström L, Lapidus A, Ost A, Bergquist A.
    Dis Colon Rectum; 2011 Nov 20; 54(11):1392-7. PubMed ID: 21979184
    [Abstract] [Full Text] [Related]

  • 17. [Recent Advances in Understanding Colorectal Cancer and Dysplasia Related to Ulcerative Colitis].
    Yang DH.
    Korean J Gastroenterol; 2015 Dec 20; 66(6):312-9. PubMed ID: 26691188
    [Abstract] [Full Text] [Related]

  • 18. Increased risk of colorectal neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis: a meta-analysis.
    Soetikno RM, Lin OS, Heidenreich PA, Young HS, Blackstone MO.
    Gastrointest Endosc; 2002 Jul 20; 56(1):48-54. PubMed ID: 12085034
    [Abstract] [Full Text] [Related]

  • 19. Nephrotic syndrome from 5-ASA for ulcerative colitis? Complicated by carcinoma of the colon and sclerosing cholangitis.
    Fornaciari G, Maccari S, Borgatti PP, Rustichelli R, Amelio N, Lattuada I, Plancher AC.
    J Clin Gastroenterol; 1997 Jan 20; 24(1):37-9. PubMed ID: 9013349
    [Abstract] [Full Text] [Related]

  • 20. Ulcerative colitis has an aggressive course after orthotopic liver transplantation for primary sclerosing cholangitis.
    Papatheodoridis GV, Hamilton M, Mistry PK, Davidson B, Rolles K, Burroughs AK.
    Gut; 1998 Nov 20; 43(5):639-44. PubMed ID: 9824344
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.